Cardiometabolic Disease
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
Scientific Publications & Presentations
Built on decades of scientific leadership, Ionis continues to advance the understanding of disease through groundbreaking research and innovation. Explore select publications across our therapeutic areas and technologies to better understand the science behind our medicines and pipeline.
Showing 13-16 out of 16 results
Cardiometabolic Disease
Olezarsen Data Presented at the 2024 American College of Cardiology Annual Meeting
Cardiometabolic Disease
N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
Cardiometabolic Disease
Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study